BROOKE RICHARDSON: Open Payments
NPI 1043742489 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 33 payments from 13 companies in 2025. Trend: 2023 $1,146 · 2024 $748 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $148 |
| Ardelyx, Inc. | 5 | $120 |
| Novo Nordisk Inc | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $44 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
Products named: IBSRELA, Kerendia, Rybelsus, AIRSUPRA, TRELEGY ELLIPTA, BREZTRI, XIFAXAN, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
